Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
about
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivoIrradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosisThe anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceU94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging.3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cellsPaclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules.Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsPhenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells.Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance.Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAILGene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cellsINGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.High cell surface death receptor expression determines type I versus type II signalingOn the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.Antiproliferative and Apoptotic Effect of Curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in Chronic Myeloid Leukaemic CellsThe pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies.Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.To kill a tumor cell: the potential of proapoptotic receptor agonistsTNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.Caspase-8 as a therapeutic target in cancer.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation.Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cellsPaclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxolInvolvement of Bax and Bcl-2 in Induction of Apoptosis by Essential Oils of Three Lebanese Salvia Species in Human Prostate Cancer Cells.
P2860
Q24650617-D9502B1E-C838-4C1B-9A5B-C1FF4A2CE847Q24798681-8A208ABE-8CBF-40E2-8A3F-943099A42EA0Q24811656-1FF707D5-45D8-4A6B-A355-52C9A8E95F7AQ24811943-BE56776E-3A23-4F44-9369-5F0A213D9DE8Q30544925-262CE8D0-3FAE-4633-883F-1AC4BECD173AQ32181056-15ECDFC0-78FC-442F-9290-9CCA9C9F0687Q33775805-56C6D307-367D-4195-893A-8644EEEACBF2Q33921228-25C44C07-C0AC-44A0-83EC-F66526FDFB76Q34106016-7E24A032-7263-4B74-9299-5A9D84B5ED4EQ34125103-D65AA626-EA16-4BCE-A08C-201EE95E7D81Q34154782-98EFA59E-D651-4F0A-958F-0C040BCEE487Q34384021-52C00312-3664-49C7-8252-B904E1D46849Q34482821-66F4A8D5-9DE3-4F38-86BF-AB3AE32EA6B7Q34595748-75F79EF2-FE70-4698-A5ED-7BF7AD21B30FQ34644792-CB2363C3-4505-4DBD-B22F-12E68CD09A42Q34700466-73A6877D-E623-455B-B491-9DB0C341361BQ35127888-99E62686-8258-4834-86DB-A4DA9BE506C0Q35136043-BB99F508-2152-4B23-8BC9-596A71F92A43Q35371553-7FA9D8AF-6C7C-460A-9A1A-B7F306AAFDBDQ35853714-90EC7382-CC6D-4EE8-95E2-728D34DE490CQ36065205-CA6F4B34-A9EE-41C9-A981-98DC65E6EDA9Q36899138-A8F500D4-AD65-4284-8545-33840BE1CCFDQ36992184-E5AFF145-79B6-4952-9533-0F9663403895Q37176101-D3E43FBD-7E0A-4250-80B3-536093EC1F45Q37178718-091338D0-EB7F-4573-B823-FF760F03B1D0Q37181734-BAA9AB13-E6B1-4573-BF67-D1C5F2BCF6FDQ37440765-87D359CA-A618-4340-AAFE-2EFC1775C75AQ37785346-EC6E8A70-B6D4-48E6-9F7D-C4798F513A25Q37972139-33432ED0-118C-4CF2-BDDC-A81F869F25FBQ38302286-343F5B16-99A0-47EC-9710-5A001228F469Q38309197-8F1BEE5A-1AE4-46DF-973D-9FDA63CD16ACQ38601765-4250972A-E87D-49E5-AB6D-DA97A35A0D7EQ38652074-0B182884-87E6-4988-9AAC-8A3C1FE72BB9Q38798516-1D7AE353-5D86-478E-AC32-ABF8D65BEF09Q39464321-566845E5-AC7C-4214-97E5-82B67BD0DC6DQ41967143-CF31B79A-ACAF-4D62-ABC8-5F64F84C6F87Q48207681-A01E2FA8-ECD5-44E4-8293-B1587CF1821F
P2860
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@ast
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@en
type
label
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@ast
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@en
prefLabel
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@ast
Pretreatment with paclitaxel e ...... eptors 4 and 5 protein levels.
@en
P2093
P1433
P1476
Pretreatment with paclitaxel e ...... ceptors 4 and 5 protein levels
@en
P2093
Nimmanapalli R
Perkins CL
P304
P407
P577
2001-01-01T00:00:00Z